Health during Olympic career and residual symptoms
| Women (n) | Prevalence % (95% CI) | Men (n) | Prevalence % (95% CI) | All (n) | Overall prevalence % (95% CI) | |
| Depression during Olympic career | 137 | 9.2 (7.7–10.7) | 81 | 4.4 (3.5–5.3)† | 221* | 6.6 (5.7–7.4) |
| Depression on retirement from Olympic career | 190 | 12.8 (11.1–14.5) | 127 | 6.9 (5.7 –8.1)† | 317 | 9.5 (8.5–10.4) |
| Asthma | 175 | 11.8 (10.1–13.4) | 103 | 5.6 (4.5–6.6)† | 280* | 8.3 (7.4–9.3) |
| Other heart problems for example, arrhythmia | 33 | 2.2 (1.5–3.0) | 23 | 1.3 (0.7–1.8) | 57* | 1.7 (1.3–2.1) |
| Regular painkiller use during career | 286 | 19.2 (17.2–21.2) | 269 | 14.6 (13.0–16.2)† | 561* | 16.7 (15.4–18.0) |
| Regular NSAIDs use during career | 513 | 34.5 (32.1–36.9) | 488 | 26.5 (24.5–28.5)† | 1001* | 29.8 (28.3–31.4) |
| Current pain from Olympic-career injuries | 560 | 37.6 (35.2 to 40.1) | 520 | 28.3 (26.2 to 30.3)† | 1087* | 32.4 (30.8 to 34.0) |
| Current functional limitation from Olympic-career injuries | 595 | 40.0 (37.5 to 42.5) | 603 | 32.7 (30.6 to 34.9) | 1204* | 35.9 (34.2 to 37.5) |
*Some sex data unknown.
†p<0.05 men to women.
NSAIDs, non-steroidal anti-inflammatory drug.